Control of extracellular matrix remodelling within ovarian tissues: Localization and regulation of gene expression of plasminogen activator inhibitor type-1 within the ovine corpus luteum

Journal of Reproduction and Fertility

Volumn 110, Issue 1, 1997, Pages 107-114

  Smith, G W ^a   Gentry, P C ^a   Bao, B ^a   Long, D K ^a   Roberts, R M ^a,b   Smith, M F ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN F2 ALPHA; PROTEIN; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; UROKINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORPUS LUTEUM; CULTURE MEDIUM; ESTRUS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCATION; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LIFESPAN; LUTEAL CELL; LUTEAL PHASE; LUTEOLYSIS; NONHUMAN; ONTOGENY; OVARY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHEEP;

ANIMALIA; OVIS; OVIS ARIES;

EID: 0030749885     PISSN: 00224251     EISSN: None     Source Type: Journal    
DOI: 10.1530/jrf.0.1100107     Document Type: Article

References (41)

1. Andreasen PA, Georg B, Lund LR, Riccio A and Stacy SN (1990) Plasminogen activator inhibitors: hormonally regulated serpins Molecular and Cellular Endocrinology 68 1-19
2. Bacharach E, Itin A and Kehset E (1992) In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis Proceedings of the National Academy of Science USA 89 10 686-10 690
3. Cajot JF, Bamat J, Bergonzelli GE, Kruithof EKO, Medcalf RL, Testuz J and Sordat B (1990) Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells Proceedings of the National Academy of Science USA 87 6939-6943
4. Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D and Mulligan RC (1993) Plasminogen activator inhibitor-1 gene-deficient mice: Generation by homologous recombination and characterization Journal of Clinical Investigation 92 2746-2755
5. Chesselet MF (1990) In situ Hybridization Histochemistry p. 203 CRC Press, Boca Raton
6. Chirgwin JM, Przybyla AE, Macdonald RJ and Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease Biochemistry 18 5294-5299
7. Chun SY, Popliker M, Reich R and Tsafriri A (1992) Localization and preovulatory expression of plasminogen activator inhibitor type-1 and tissue inhibitor of metalloproteinase type-1 mRNAs in the rat ovary Biology of Reproduction 47 245-253
8. Eaton DL, Scott RW and Baker JB (1984) Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin Journal of Biological Chemistry 259 6241-6247
9. Espey LL and Lipner H (1994) Ovulation. In The Physiology of Reproduction pp 725-780 Eds E Knobil and JD Neill. Raven Press, New York
10. Feinberg RF, Kao LC, Haimowitz JE, Queenan JT, Jr, Wun TC, Strauss JF, III and Kliman HJ (1989) Plasminogen activator inhibitors types 1 and 2 in human trophoblasts Laboratory Investigation 61 20-26
11. Fitz TA, Mayan MH, Sawyer HR and Niswender GD (1982) Characterization of two steroidogenic cell types in the ovine corpus luteum Biology of Reproduction 27 703-711
12. Getzenberg RH, Pienta KJ and Coffey DS (1990) The tissue matrix: Cell dynamics and hormone action Endocrine Reviews 11 399-417
13. Hart DA and Rehemtulla A (1988) Plasminogen activators and their inhibitors: Regulators of extracellular proteolysis and cell function Comparative Biochemistry and Physiology 90B 691-708
14. Keisler DH and Keisler LW (1989) Formation and function of GnRH induced subnormal corpora lutea in cyclic ewes Journal of Reproduction and fertility 87 265-273
15. Knudsen H, Olesen T, Riccio A, Ungaro P, Christensen L and Andreasen PA (1994) A common response element mediates differential effects of phorbol esters and forskolin on type-1 plasminogen activator inhibitor gene expression in human breast carcinoma cells European Journal of Biochemistry 220 63-74
16. Li J and Roberts RM (1994} Interferon-τ and interferon α interact with the same receptors in bovine endometrium: use of a readily iodinatable form of interferon τ for binding studies Journal of Biological Chemistry 269 13544-13550
17. Liu K, Brandstrom A, Liu Y, Ny T and Selstam G (1996) Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat Endocrinology 137 2126-2132
18. Loskutoff DJ, Linders M, Keijer J, Veerman H, van Heerikhuizen H and Pannekoek H (1987) Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns Biochemistry 26 3763-3768
19. Lucore CL, Fujii S, Wun TC, Sobel BE and Billadello JJ (1988) Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor Journal of Biological Chemistry 263 15845-15848
20. Mignatti P, Robbins E and Rifkin DB (1986) Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade Cell 47 487-498
21. Mimuro J, Sawdey M, Hattori M and Loskutoff DJ (1989) cDNA for bovine type 1 plasminogen activator inhibitor Nucleic Acids Research 17 8872
22. Nargolwalla C, McCabe D and Fritz IB (1990) Modulation of levels of messenger RNA for tissue type plasminogen activator in rat Sertoli cells, and levels of messenger RNA for plasminogen activator inhibitor in testis peritubular cells Molecular and Cellular Endocrinology 70 73-80
23. Ny T, Peng XR and Ohlsson M (1993) Hormonal regulation of the fibrinolytic components in the ovary Thrombosis Research 71 1-45
24. Peng XR, Hsueh AJW and Ny T (1993) Transient and cell specific expression of tissue type plasminogen activator and plasminogen activator inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation European Journal of Biochemistry 214 147-156
25. Piquette GN, Crabtree ME, El-Danasouri I, Milki A and Lake-Polan ML (1993) Regulation of plasminogen activator inhibitor-1 and-2 messenger ribonucleic acid levels in human cumulus and granulosa-luteal cells Journal of Clinical Endocrinology and Metabolism 76 518-523
26. Qiang F, Kui L, Zhao-yuan H, Ru-jin Z, Sahng Y and Yi-xun L (1993) The possible involvement of tissue type plasminogen activator in luteolysis of rhesus monkey Human Reproduction 8 1640-1644
27. Rao JS, Chen M and Festoff BW (1993) Plasminogen activator inhibitor 1, the primary regulator of fibrinolysis, in normal human cerebrospinal fluid Journal of Neuroscience Research 34 340-345
28. Roberts RM, Mathialagan N, Duffy JY and Smith GW (1995) Regulation and regulatory role of proteinase inhibitors Critical Reviews in Eukaryotic Gene Expression 5 385-436
29. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning. A Laboratory Manual (2nd Edn). Cold Spring Harbor Laboratory Press, Cold Spring Harbor
30. Schleef RR, Podor TJ, Dunne E, Mimuro J and Loskutoff DJ (1990) The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution phase tissue type plasminogen activator Journal of Cell Biology 110 155-163
31. Smith GW, Moor RM and Smith MF (1993) Identification of a 30,000 Mr polypeptide secreted by cultured granulosa cells and luteal tissue as a tissue inhibitor of metalloproteinases Biology of Reproduction 48 125-132
32. Smith GW, Goetz TL, Anthony RV and Smith MF (1994) Molecular cloning of an ovine ovarian tissue inhibitor of metalloproteinases: Ontogeny of messenger ribonucleic acid expression and in situ localization within preovulatory follicles and luteal tissue Endocrinology 134 344-352
33. Smith GW, McCrone S, Petersen SL and Smith MF (1995) Expression of messenger ribonucleic acid encoding tissue inhibitor of metalloproteinases-2 within ovine follicles and corpora lutea Endocrinology 136 570-576
34. Smith GW, Gentry PC, Roberts RM and Smith MF (1996) Ontogeny and regulation of luteinizing hormone receptor messenger ribonucleic acid within the ovine corpus luteum Biology of Reproduction 54 76-83
35. Smith MF, McIntush EW and Smith GW (1994) Mechanisms associated with corpus luteum development Journal of Animal Science 72 1857-1872
36. Smith PK, Krohn RI, Hermanson GT, Malia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC (1985) Measurement of protein using bicinchoninic acid Analytical Biochemistry 150 76-85
37. Thorsen S, Phillips M, Selmer J, Lecander I and Aastedt B (1988) Kinetics of inhibition of tissue type and urokinase type plasminogen activator by plasminogen activator inhibitor type 1 and type 2 European Journal of Biochemistry 175 33-39
38. Tryggvason K, Hoyhtya M and Salo T (1987) Proteolytic degradation of extracellular matrix in tumor invasion Biochemica et Biophysica Acta 907 191-217
39. Van Mourik JA, Lawrence DA and Loskutoff DJ (1984) Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells Journal of Biological Chemistry 259 14 914-14 921
40. Wiltbank MC, Diskin MG and Niswender GD (1991) Differential actions of second messenger systems in the corpus luteum Journal of Reproduction and Fertility Supplement 43 65-75
41. Yi-xun L, Ya-xiong C, Fa-wu S and Qiang F (1995) Studies on the role of plasminogen activators and plasminogen activator inhibitor type-1 in rat corpus luteum of pregnancy Biology of Reproduction 53 1131-1138